Oncolytics Biotech (ONCY) Exchange Rate Effect (2009 - 2025)

Oncolytics Biotech (ONCY) has reported Exchange Rate Effect for 17 consecutive years, with $1.2 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Exchange Rate Effect rose 100.01% year-over-year to $1.2 million in Q4 2025; TTM through Dec 2025 was $966276.3, a 16.94% decrease from a year earlier, with the FY2025 full-year figure at $121000.0, up 141.87% from the prior year.
• Exchange Rate Effect was $1.2 million for Q4 2025 at Oncolytics Biotech, up from $178752.2 in the prior quarter.
• Over five years, Exchange Rate Effect peaked at $1.4 million in Q3 2022 and troughed at -$602028.0 in Q2 2021.
• A 5-year average of $152487.9 and a median of $24333.4 in 2025 frame the typical range for Exchange Rate Effect.
• Across the five-year window, Exchange Rate Effect jumped 650.87% in 2024 and tumbled 332.33% in 2025, its largest moves.
• Over 5 years, Exchange Rate Effect stood at -$288757.7 in 2021, then rose by 28.56% to -$206276.8 in 2022, then slumped by 143.57% to -$502422.3 in 2023, then jumped by 222.1% to $613482.7 in 2024, then jumped by 100.01% to $1.2 million in 2025.
• The last three Exchange Rate Effect figures came in at $1.2 million (Q4 2025), $178752.2 (Q3 2025), and -$417871.5 (Q2 2025), per Business Quant data.